memantine hydrochloride NDC 68180-247

NDC codes

FDA NDC Directory

Product NDC (as listed)68180-247Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68180-0247Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68180-247-06	68180024706	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68180-247-06)Marketed from Feb 20, 2018
68180-247-09	68180024709	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68180-247-09)Marketed from Feb 20, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): memantine hydrochloride
Generic name (nonproprietary): memantine hydrochloride
Active ingredients: Memantine hydrochloride — 14 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Lupin Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206028
Marketing start: Feb 20, 2018
Listing expires: Dec 31, 2027
Other FDA classes: NMDA Receptor Antagonists (Mechanism)
Identifiers: Product ID 68180-247_2eba035e-38ce-479d-8dc8-0bfdd2bffbcfSPL ID 2eba035e-38ce-479d-8dc8-0bfdd2bffbcfSPL set ID 24290655-47f3-4042-a977-a832c5161d2cRxCUI 996594, 996603, 996609, 996615UNII JY0WD0UA60UPC 0368180247067, 0368180249061, 0368180246060
Pharmacologic class: N-methyl-D-aspartate Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468180024706 followed by a unit qualifier and the quantity

Package 68180-0247-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 15, 2026.

Indications (excerpt from the label)

Memantine hydrochloride extended-release capsules are a N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer's type. ( 1 ) Memantine hydrochloride extended-release capsules are indicated for the treatment of moderate to severe dementia of the Alzheimer's type.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 206028

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206028
Product	Strength	Form · route	Labeler	Product NDC
memantine hydrochloride	Memantine hydrochloride 7 mg/1	Capsule, Extended releaseOral	Major Pharmaceuticals	0904-6734
memantine hydrochloride	Memantine hydrochloride 28 mg/1	Capsule, Extended releaseOral	Major Pharmaceuticals	0904-6735
memantine hydrochloride	Memantine hydrochloride 7 mg/1	Capsule, Extended releaseOral	Lupin Pharmaceuticals, Inc.	68180-246
memantine hydrochloride	Memantine hydrochloride 21 mg/1	Capsule, Extended releaseOral	Lupin Pharmaceuticals, Inc.	68180-248
memantine hydrochloride	Memantine hydrochloride 28 mg/1	Capsule, Extended releaseOral	Lupin Pharmaceuticals, Inc.	68180-249